Healthy men test new Drug's safety and body processing
NCT ID NCT02068690
First seen May 05, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This early-stage study tested a single dose of an experimental drug called BI 425809 in 83 healthy men. The main goal was to check for side effects and see how the drug moves through the body. Researchers also compared a liquid form to a tablet and looked at whether food changes how the drug is absorbed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
1346.1.1 Boehringer Ingelheim Investigational Site
Ingelheim, Germany
Conditions
Explore the condition pages connected to this study.